Navigation Links
Heart Health Month Milestone: Half a Billion Pounds of Bad Fats Eliminated From North American Diet
Date:2/25/2009

Omega-9 Canola and Sunflower Oils drive better restaurant menu options

INDIANAPOLIS, Feb. 25 /PRNewswire/ -- This year's Heart Health Month marks a significant milestone in North America with the reduction of nearly a half billion pounds of trans and saturated fats over the past three years. Since the market introduction in 2006, Omega-9 Canola and Sunflower Oils, developed by Dow AgroSciences, have replaced more than 340 million pounds of trans fat, and 130 million pounds of saturated fat, both of which have been shown to increase the risk of coronary heart disease, and other chronic health problems.

"Trans and saturated fats increase the risk for a variety of heart conditions," said Dr. Penny Kris-Etherton, distinguished professor at Penn State University's Nutritional Sciences Department. "So this Heart Health Month, we encourage people to ask their favorite restaurants to use healthier cooking oils that are not only zero trans fat, but also low in saturated fat and high in monounsaturated fat."

"The foodservice industry has embraced the health concerns of their customers and is aware of how important this issue is to them. It's exciting to have reached such a milestone so quickly, working with restaurant owners and operators who use Omega-9 Oils for the health of their customers, without sacrificing the taste of their fried items," said David Dzisiak, Commercial Leader Oils Business Unit for Dow AgroSciences. "And because there has been so much demand for Omega-9 Oils, we have plans to ramp-up annual oil production to 2.5 billion pounds by 2012."

And as foodservice operators learn about the benefits of using Omega-9 Oils in their kitchens, more and more are converting to it. Those restaurants and chains include Taco Bell, The Compass Group, Bon Appetit Management Company, Memorial Sloan-Kettering Cancer Center, BurgerVille, Biscuitville, Fatz Cafe, Ina's, Rush University Medical Center, Daphne's Greek Cafe, and Associated Food Stores.

"We converted to Omega-9 Canola Oil across our thousands of operations nationally for the health of our customers," said Deanne Brandstetter, Vice President, Nutrition and Wellness, Compass Group North America. "Doing so allowed us to not only eliminate trans fat, but also lower the amount of saturated fat in fried items."

Omega-9 Canola and Sunflower Oils are made from naturally bred NEXERA(TM) canola and sunflower seeds developed by Dow AgroSciences. These Omega-9 Oils are the "next generation" in cooking oils due to their unique features of superior taste, health and performance. Capacity to provide more than one billion pounds of Omega-9 Oils enables the immediate conversion by foodservice and food processing companies to a zero trans fat alternative.

About Compass Group North America

Based in Charlotte NC, Compass Group North America is the leading foodservice and support services company with more than $9 billion in revenues in 2008. With 388,000 associates worldwide, its parent company, UK-based Compass Group PLC had revenues of 11 billion pounds Sterling in the year to September 30, 2008. www.cgnad.com.

About Dow AgroSciences

Dow AgroSciences LLC, based in Indianapolis, Indiana, USA, is a top-tier agricultural company that combines the power of science and technology with the "Human Element" to constantly improve what is essential to human progress. Dow AgroSciences provides innovative technologies for crop protection, pest and vegetation management, seeds, traits, and agricultural biotechnology to serve the world's growing population. Global sales for Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company, are $4.5 billion. Learn more at www.dowagro.com.

(TM)NEXERA is a trademark of Dow AgroSciences LLC


'/>"/>
SOURCE Dow AgroSciences LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. VAP Test Demonstrates Value of Fish Oil in Reducing Heart Risk for Super Bowl Champs
2. KanekaQH(TM) Ubiquinol Dramatically Boosts Ejection Fraction in Patients With Late-Stage Congestive Heart Failure
3. VAP Cholesterol Test Helps In Search For New Heart Disease Drugs
4. Cordex Pharma Forms Heart Failure Medical Advisory Board
5. Multinational deCODE Study Identifies New Link Between Inflammation and Heart Attack
6. BioIQ Supports American Heart Month to Raise Awareness About Heart Disease, the #1 Killer of Women
7. Traditional Risk Factors Often Miss Heart Disease Warning Signs
8. New Multi-Center Study Finds Masimo SET Pulse Oximetry Screening Significantly Improves Detection of Congenital Heart Disease in Newborns
9. Nile Therapeutics Announces Focus on CD-NP for Acute Heart Failure and Termination of 2NTX-99 Program
10. Medical Machines Online Announces Release of a Brand New Philips HeartStart AED Defibrillator
11. Nile Therapeutics Announces Positive Results from Phase 1b Safety and Pharmacodynamics Study of CD-NP in Patients with Heart Failure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young ... cancer. Members of the Class of 2016 were selected from a pool of ... More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published ... how a patient who developed lymphedema after being treated for breast cancer benefitted from ... the paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... is exhibiting at the Pennsylvania Convention Center and will showcase its product’s latest ... ClinCapture will also be presenting a scientific poster on Disrupting Clinical Trials in ...
Breaking Biology Technology:
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing ...  3D medical LCD display is the latest premium product recently added to the range ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/9/2016)... DUBAI , UAE, May 9, 2016 ... choice when it comes to expanding freedom for high ... Even in today,s globally connected world, there ... online conferencing system could ever duplicate sealing your deal ... are obtaining second passports by taking advantage of citizenship ...
(Date:4/26/2016)... India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a product ... and Onegini today announced a partnership to integrate ... solutions.      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ... to provide their customers enhanced security to access ...
Breaking Biology News(10 mins):